Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MARGETTS, P. J.
Right arrow Articles by GAULDIE, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MARGETTS, P. J.
Right arrow Articles by GAULDIE, J.
J Am Soc Nephrol 12:2029-2039, 2001
© 2001 American Society of Nephrology

Gene Transfer of Transforming Growth Factor-ß1 to the Rat Peritoneum: Effects on Membrane Function

PETER J. MARGETTS*,{dagger}, MARTIN KOLB{dagger}, TOM GALT{dagger}, CATHERINE M. HOFF{ddagger}, TY R. SHOCKLEY{ddagger} and JACK GAULDIE{dagger}

* Division of Nephrology, McMaster University, Hamilton, Canada
{dagger} Centre for Gene Therapeutics, McMaster University, Hamilton, Canada
{ddagger} Renal Division Scientific Affairs, Baxter Healthcare Corp., McGaw Park, Illinois.

Correspondence to Dr. Jack Gauldie, Department of Pathology and Molecular Medicine, McMaster University, 1200 Main Street W., Room 2N16, Hamilton, Ontario, Canada L8N 3Z5. Phone: 905-521-2100, ext. 76332; Fax: 905-577-0198; E-mail: gauldie{at}mcmaster.ca

Abstract. Long-term peritoneal dialysis is limited by physiologic changes in the peritoneum that lead to ultrafiltration failure. To determine the role of profibrotic cytokines in the alteration of peritoneal transport, a rodent model of transforming growth factor-ß (TGF-ß)-mediated peritoneal fibrosis was established. An adenoviral vector driving the active form of TGF-ß1 (AdTGFß1) was administered intraperitoneally, and peritoneal structure and function were evaluated for 28 d after infection. Seven days after AdTGFß1 infection, thickening of the peritoneum, with cellular proliferation and increased vascularization, was noted. By day 28, there was persistent thickening and extensive collagen deposition. The mesenteric collagen content was significantly elevated, compared with control adenovirus-treated animals, 21 d after infection (2.9 versus 1.8 mg hydroxyproline/g tissue, P = 0.006). Blood vessel density, as measured using factor VIII immunohistochemical analyses, was significantly increased from day 4 to day 21 but decreased by day 28. Animals infected with AdTGFß1 demonstrated increased transport of solutes and decreased net ultrafiltration, which was maximal on day 7 and returned to baseline levels by day 28. It was demonstrated in vitro and in vivo that TGF-ß1 induced production of vascular endothelial growth factor. Overexpression of TGF-ß1 after adenovirus-mediated gene transfer causes peritoneal fibrosis, neoangiogenesis, and increased peritoneal membrane solute transport. This model should allow further delineation of the relative contributions of profibrotic and angiogenic cytokines to changes in peritoneal function and may lead to potential new interventions for peritoneal membrane failure.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
I. Kolesnyk, M. Noordzij, F. W. Dekker, E. W. Boeschoten, and R. T. Krediet
A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients
Nephrol. Dial. Transplant., January 1, 2009; 24(1): 272 - 277.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. Cina, P. Patel, J. C. Bethune, J. Thoma, J. C. Rodriguez-Lecompte, C. M. Hoff, L. Liu, and P. J. Margetts
Peritoneal morphological and functional changes associated with platelet-derived growth factor B
Nephrol. Dial. Transplant., September 4, 2008; (2008) gfn498v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Nishimura, Y. Ito, M. Mizuno, A. Tanaka, Y. Morita, S. Maruyama, Y. Yuzawa, and S. Matsuo
Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model
Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1084 - F1093.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Decologne, M. Kolb, P. J. Margetts, F. Menetrier, Y. Artur, C. Garrido, J. Gauldie, P. Camus, and P. Bonniaud
TGF-beta1 Induces Progressive Pleural Scarring and Subpleural Fibrosis
J. Immunol., November 1, 2007; 179(9): 6043 - 6051.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
Y. Ro, C. Hamada, M. Inaba, H. Io, K. Kaneko, and Y. Tomino
Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats
Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2838 - 2848.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. Guo, J. C.K. Leung, M. F. Lam, L. Y.Y. Chan, A. W.L. Tsang, H. Y. Lan, and K. N. Lai
Smad7 Transgene Attenuates Peritoneal Fibrosis in Uremic Rats Treated with Peritoneal Dialysis
J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2689 - 2703.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
L. S. Aroeira, A. Aguilera, J. A. Sanchez-Tomero, M. A. Bajo, G. del Peso, J. A. Jimenez-Heffernan, R. Selgas, and M. Lopez-Cabrera
Epithelial to Mesenchymal Transition and Peritoneal Membrane Failure in Peritoneal Dialysis Patients: Pathologic Significance and Potential Therapeutic Interventions
J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2004 - 2013.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C.-C. Fang, C.-J. Yen, Y.-M. Chen, T.-S. Chu, M.-T. Lin, J.-Y. Yang, and T.-J. Tsai
Diltiazem suppresses collagen synthesis and IL-1{beta}-induced TGF-{beta}1 production on human peritoneal mesothelial cells
Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1340 - 1347.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
B. A. Vallance, M. I. Gunawan, B. Hewlett, P. Bercik, C. Van Kampen, F. Galeazzi, P. J. Sime, J. Gauldie, and S. M. Collins
TGF-{beta}1 gene transfer to the mouse colon leads to intestinal fibrosis
Am J Physiol Gastrointest Liver Physiol, July 1, 2005; 289(1): G116 - G128.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. F. Flessner
The transport barrier in intraperitoneal therapy
Am J Physiol Renal Physiol, March 1, 2005; 288(3): F433 - F442.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. J. Margetts, P. Bonniaud, L. Liu, C. M. Hoff, C. J. Holmes, J. A. West-Mays, and M. M. Kelly
Transient Overexpression of TGF-{beta}1 Induces Epithelial Mesenchymal Transition in the Rodent Peritoneum
J. Am. Soc. Nephrol., February 1, 2005; 16(2): 425 - 436.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y. Motomura, H. Kanbayashi, W. I. Khan, Y. Deng, P. A. Blennerhassett, P. J. Margetts, J. Gauldie, K. Egashira, and S. M. Collins
The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-{beta} type II receptor gene transfer
Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G143 - G150.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Nakamura and T. Niwa
Pyridoxal Phosphate and Hepatocyte Growth Factor Prevent Dialysate-Induced Peritoneal Damage
J. Am. Soc. Nephrol., January 1, 2005; 16(1): 144 - 150.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. D. Martin-Martinez, M. Stoenoiu, C. Verkaeren, O. Devuyst, and C. Delporte
Recombinant adenovirus administration in rat peritoneum: endothelial expression and safety concerns
Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1293 - 1297.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. Yanez-Mo, E. Lara-Pezzi, R. Selgas, M. Ramirez-Huesca, C. Dominguez-Jimenez, J. A. Jimenez-Heffernan, A. Aguilera, J. A. Sanchez-Tomero, M. A. Bajo, V. Alvarez, et al.
Peritoneal Dialysis and Epithelial-to-Mesenchymal Transition of Mesothelial Cells
N. Engl. J. Med., January 30, 2003; 348(5): 403 - 413.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. J. Margetts, M. Kolb, L. Yu, C. M. Hoff, C. J. Holmes, D. C. Anthony, and J. Gauldie
Inflammatory Cytokines, Angiogenesis, and Fibrosis in the Rat Peritoneum
Am. J. Pathol., June 1, 2002; 160(6): 2285 - 2294.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. J. Margetts, S. Gyorffy, M. Kolb, L. Yu, C. M. Hoff, C. J. Holmes, and J. Gauldie
Antiangiogenic and Antifibrotic Gene Therapy in a Chronic Infusion Model of Peritoneal Dialysis in Rats
J. Am. Soc. Nephrol., March 1, 2002; 13(3): 721 - 728.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP